Taltz and Tuberculosis - a phase IV clinical study of FDA data

Summary:

Tuberculosis is reported as a side effect among people who take Taltz (ixekizumab), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Humira, and have Psoriasis.

The phase IV clinical study analyzes which people have Tuberculosis when taking Taltz. It is created by eHealthMe based on reports of 29,745 people who have side effects when taking Taltz from the FDA, and is updated regularly.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,777 Taltz users. Check the latest studies of Taltz.

What is Tuberculosis?

Tuberculosis (a bacterial infection by mycobacterium tuberculosis) is found to be associated with 629 drugs and 766 conditions by eHealthMe. Check the latest studies of Tuberculosis.

On Jul, 04, 2026

29,745 people reported to have side effects when taking Taltz.
Among them, 53 people (0.18%) have Tuberculosis.

Among these 53 people:

How long have people been on Taltz when they have Tuberculosis? *

What is the gender of people who have Tuberculosis when taking Taltz? *

female: 51.16 %
male: 48.84 %

What is the age of people who have Tuberculosis when taking Taltz? *

What are other drugs people take besides Taltz? *

What are other side effects people have besides Tuberculosis? *

Drug Ineffective: 4 people, 7.55%
Drug Hypersensitivity: 3 people, 5.66%
Infection: 2 people, 3.77%
Optic Neuritis (optic nerve inflammation): 2 people, 3.77%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 1.89%
Adverse Drug Reaction: 1 person, 1.89%
Cardiac Disorder: 1 person, 1.89%
Coughing Up Blood: 1 person, 1.89%
Depression: 1 person, 1.89%
Drug Intolerance (drug sensitivity): 1 person, 1.89%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 16 people, 30.19%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 7.55%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 5.66%
Stress And Anxiety: 2 people, 3.77%
Depression: 2 people, 3.77%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.89%
Erythrodermic Psoriasis (generalized redness of the skin): 1 person, 1.89%

* Approximation only. Some reports may have incomplete information.

Do you take Taltz and have Tuberculosis?

- Check whether Tuberculosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taltz:

Taltz (29,777 reports)

Tuberculosis treatments and more:

Tuberculosis (26,436 reports)

Browse all side effects of Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tuberculosis:

Tuberculosis (629 drugs)

Browse all the conditions that are associated with Tuberculosis:

Tuberculosis (766 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ixekizumab (the active ingredients of Taltz) and Taltz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.